Industries > Pharma > Global Allergic Rhinitis Drugs Market 2017-2027

Global Allergic Rhinitis Drugs Market 2017-2027

Oral Antihistamines, Intranasal Corticosteroids, Intranasal Antihistamines, Immunotherapy and Vaccines

PUBLISHED: 30 May 2017
PAGES: 255
PRODUCT CODE: PHA0196
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
SKU: PHA0196 Categories: ,

The global allergic rhinitis drugs market is expected to grow at a CAGR of 3.2% in the first half of the forecast period. The market is expected to grow at a CAGR of 3.3% from 2016-2027. The market is estimated at $11.9bn in 2016 and $13.9bn in 2021.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 255-page report you will receive 85 tables and 88 figures – all unavailable elsewhere.

The 255-page report provides clear detailed insight into the global allergic rhinitis drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Global Allergic Rhinitis Drugs Market forecasts from 2017-2027

• Along with revenue prediction for the overall world market for allergic rhinitis drugs, our investigation shows forecasts to 2027 for the following submarkets:
– Intranasal Antihistamines
– Intranasal Corticosteroids
– Oral Antihistamines
– Immunotherapy and Vaccines

• How will leading allergic rhinitis drugs perform to 2027 at world level? Our study forecasts individual revenues of these 27 products:
– Patanase
– Astepro
– Astelin
– Dymista
– Nasonex
– Avamys
– Veramyst
– Flixonase
– Rhinocort
– Omnaris
– Nasacort
– Beconase
– Qnasl
– Zetonna
– Allegra
– Zyrtec
– Claritin
– Xyzal
– Allelock
– Clarinex
– Ebastel
– Talion
– Staloral
– Alutard SQ
– Grazax
– Ragwitek
– Generic Azelastine

Global Allergic Rhinitis Drugs Market 2017-2027

• This report provides individual revenue forecasts to 2027 for these regional and national markets:
– US
– EU5 – Germany, UK, France, Italy and Spain
– China
– Japan
– India
– Russia
– Brazil
– Rest of the World

• Our work provides analysis and sales forecast of the leading companies in the allergic rhinitis drugs market:
GlaxoSmithKline (GSK)
– Merck & Co
– Sanofi
– Johnson & Johnson
– ALK-Abello
– UCB
– Kyowo Hako Kirin
– Stallergenes Greer

• This report discusses the trends and development in the allergic rhinitis pipeline

• Our study discusses strengths, weaknesses, opportunities and threats as well as porter’s five forces analysis of the global allergic rhinitis drugs market

Visiongain’s study is intended for anyone requiring commercial analyses for the global allergic rhinitis drugs market. You find data, trends and predictions.

Buy our report today Global Allergic Rhinitis Drugs Market 2017-2027: Oral Antihistamines, Intranasal Corticosteroids, Intranasal Antihistamines, Immunotherapy and Vaccines.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Allergic Rhinitis Drugs Market 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Allergic Rhinitis Drugs Market 2017-2027


Latest Pharma news

Visiongain Publishes Big Data Analytics in Healthcare Market Report 2021-2031

Healthcare has never been more personalized and affordable to anyone. Digital consulting applications use artificial intelligence to provide medical advice based on customized medical history record reviews and general medical information derived from big data inferences.

13 May 2021

READ

Visiongain Publishes NGS-Based RNA Sequencing Market Report 2021-2031

The market is expected to be driven by key factors such as rising cancer prevalence, government funding support in genetic research and technological advancements taking place in the biological research field. In addition, the market is predicted to gain huge traction in the developing countries.

11 May 2021

READ

Visiongain Publishes Single-Use Bioreactors Market Report 2021-2031

Strong product portfolio in the market is one of the major factors accelerating the growth of the market as availability of variants in the single-use systems allows targeted users more options.

11 May 2021

READ

Visiongain Publishes ePharmacy Market Report 2021-2031

The growth in online shopping has been driven by a rapid rise in the number of smartphones, broadband connections and innovative payment products, although security remains the biggest concern. With the evolving market dynamics, merchants’ payment needs are also changing.

06 May 2021

READ

Categories